After graduating from Universiteit Utrecht with a Master of Science in Medical Biotechnology, Froucke began her career at Astellas Pharma as a pharmacovigilance scientist. Within Astellas, she then moved into bio-analytics (clinical) and clinical supply positions, later becoming a manufacturing lead for SynCo Bio Partners B.V. In this role, she was responsible for training, quality systems and planning operational activities. After holding these various positions in the pharmaceutical development process, she moved into a leading position in Regulatory Affairs (RA), initially with a company specializing in Pre-Approval Access to Patient and now with Organon holding a global Program lead role managing the regulatory operation of various source change project across 140 markets across the globe.
Organon, here for her health
Organon is an independent global healthcare company with a strategy to improve the health of women throughout their lives. Our diverse portfolio across women's health, biosimilars, and established brands includes therapies and products for a wide range of conditions and diseases.
Our vision is a better and healthier every day for every woman.
Organons portfolio encompasses more than 70 medicines and devices across a range of areas including reproductive health, cardiovascular disease, neurology, dermatology, autoimmune, and respiratory conditions. We bring these important therapies to more than 140 markets around the world.
Powered by: BCF Courses BV | Connect with us | Join BioBusiness Summer School | |||
Privacy Policy Terms & Conditions Chamber of Commerce: 75874415 | | REGISTER NOW |
© Copyright 2020 by BCF Courses